This announcement details the approval of a capital increase of $4.9 million for Hebei Baiyang Sapu Medical Equipment Technology Co., Ltd. by Qingdao Baiyang Pharmaceutical Co., Ltd. The decision was made during the board meeting on November 19, 2025. The capital increase aims to enhance the subsidiary's operational capabilities. As of the announcement date, the agreement has been signed and the transaction completed.
Summary generated by AI · Always verify with source document
To meet the operational development needs of Hebei Baiyang Sapu Medical Equipment Technology Co., Ltd. (hereinafter referred to as "Baiyang Sapu") and to strengthen its capital strength, Qingdao Baiyang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") held the third meeting of the fourth board of directors on November 19, 2025, and approved the proposal regar
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.